Trial Comparing hCG Triggering Versus GnRH Agonist Triggering in PCOS Patients

• Status: Completed
• Trial end date: 2015-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

In this study the investigators compare the traditional way of triggering with a new way in patients with Poly Cystic Ovary Syndrome (PCOS). This to reduce the risque of Ovary Hyper Stimulation Syndrome (OHSS) in In Vitro Fertilization/ IntraCytoplastic Sperm Injection (IVF/ ICSI) treatment. The investigators also compare the number of mature oocytes, embryo's and pregnancy rate.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AZ Jan Palfijn Gent
• Collaborator: Onze Lieve Vrouw Hospital
• Treatments: Deslorelin; Triptorelin Pamoate

Criteria

Inclusion Criteria:

• ICSI patients below 38 years

• 1, 2 and 3e IVF cycle

• Body Mass Index (BMI) less than 32

• PCOS patients

Exclusion Criteria:

• endocrinal diseases or problems